Literature DB >> 17638085

Metastatic pancreatic neuroendocrine tumor presenting as a pituitary space occupying lesion: a case report.

Chamutal Gur1, Gadi Lalazar, Asher Salmon, Victoria Dubiner, David J Gross.   

Abstract

Neuroendocrine tumor metastases to the pituitary gland are very rare. There are few case reports of carcinoid tumor metastases to the pituitary, but no cases of pancreatic neuroendocrine pituitary metastases have been reported. In this report we present a 55-year-old female with a sellar mass, ophthalmoplegia and headaches initially thought to represent an invasive null cell pituitary adenoma. However a histological (trans-sphenoidal and liver biopsies) and systemic investigation proved it to be a metastasis of an undiagnosed pancreatic neuroendocrine tumor. Our patient was unique in respect to the location of the metastasis and the uncharacteristically high proliferative index of her tumor. She received conventional therapy consisting of Sandostatin, chemotherapy and radiotherapy as well as labeled somatostatin following an avid uptake on octreotide scanning. Despite a radiological improvement the patient suffered progressive clinical deterioration and died.

Entities:  

Mesh:

Year:  2008        PMID: 17638085     DOI: 10.1007/s11102-007-0053-7

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  23 in total

Review 1.  Surgical treatment of non-functioning pancreatic islet cell tumors.

Authors:  Maria A Kouvaraki; Carmen C Solorzano; Suzanne E Shapiro; James C Yao; Nancy D Perrier; Jeffrey E Lee; Douglas B Evans
Journal:  J Surg Oncol       Date:  2005-03-01       Impact factor: 3.454

Review 2.  Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors.

Authors:  Thierry Delaunoit; Joseph Rubin; Florence Neczyporenko; Charles Erlichman; Timothy J Hobday
Journal:  Mayo Clin Proc       Date:  2005-04       Impact factor: 7.616

3.  Complete histological regression of metastatic carcinoid tumour after treatment with octreotide.

Authors:  K E Imtiaz; P Monteith; A Khaleeli
Journal:  Clin Endocrinol (Oxf)       Date:  2000-12       Impact factor: 3.478

Review 4.  Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.

Authors:  R Arnold
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-08       Impact factor: 3.043

5.  Malignant bronchial carcinoid tumor metastatic to the pituitary in a thyroid carcinoma patient: successful treatment with surgery, radiotherapy and somatostatin analog.

Authors:  Ilan Shimon; Moshe Hadani; Dvora Nass; S Tzila Zwas
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

6.  A metastatic pituitary carcinoid tumor successfully treated with gamma knife radiosurgery.

Authors:  M C Huang; L S Lee; D M Ho; H Cheng; W Y Chung; C I Huang; C Y Hsiao; D H Pan
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2001-07

Review 7.  Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.

Authors:  P Tomassetti; M Migliori; S Lalli; D Campana; V Tomassetti; R Corinaldesi
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

Review 8.  Metastases to the pituitary gland.

Authors:  Daniel R Fassett; William T Couldwell
Journal:  Neurosurg Focus       Date:  2004-04-15       Impact factor: 4.047

Review 9.  The diagnosis and medical management of advanced neuroendocrine tumors.

Authors:  Gregory A Kaltsas; G Michael Besser; Ashley B Grossman
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  5 in total

Review 1.  Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis.

Authors:  Wenzhuan He; Fangxiang Chen; Brian Dalm; Patricia A Kirby; Jeremy D W Greenlee
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 2.  Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review.

Authors:  Ribal Al-Aridi; Katia El Sibai; Pingfu Fu; Mehreen Khan; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

3.  Pituitary metastasis: a rare condition.

Authors:  Aida Javanbakht; Massimo D'Apuzzo; Behnam Badie; Behrouz Salehian
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

Review 4.  Pituitary metastasis: a clinical overview.

Authors:  Adam Henry; Ailish Nugent; Ian R Wallace; Bode Oladipo; Oonagh Sheehy; Philip C Johnston
Journal:  Ulster Med J       Date:  2021-11-11

Review 5.  Pituitary metastases from neuroendocrine neoplasms: case report and narrative review.

Authors:  Alberto Ragni; Alice Nervo; Mauro Papotti; Nunzia Prencipe; Francesca Retta; Daniela Rosso; Marta Cacciani; Giuseppe Zamboni; Francesco Zenga; Silvia Uccella; Paola Cassoni; Marco Gallo; Alessandro Piovesan; Emanuela Arvat
Journal:  Pituitary       Date:  2021-08-03       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.